A Study to Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia in an Older Adult Population Aged 76 Years or Older in Finland
Clinical trial NCT07502560 · RECRUITING
Trial details
- NCT number
- NCT07502560
- Sponsor
- GlaxoSmithKline
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-31
- Primary completion
- 2030-04-01
- Enrollment
- 33609
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.